Medytox Appoints Tae-sang Lee as Executive Director of Clinical Development Division
"Global Clinical Expert"
Medytox, a biopharmaceutical company led by CEO Hyunho Jung, announced on April 1 that it has appointed Tae-sang Lee as Executive Director overseeing the Clinical Development Division.
After earning a Ph.D. in pharmacy from Chung-Ang University, Executive Director Lee worked for more than 20 years at the global clinical team of Janssen Korea, where he managed the entire clinical development cycle and led regulatory approvals in the United States and Europe. Most recently, he served as Asia-Pacific leader, successfully spearheading numerous new drug development and overseas approval projects.
Tae-Sang Lee, Executive Director of Development Headquarters at Medytox. Medytox
View original imageMedytox plans to further enhance its capabilities in establishing and managing global clinical strategies and accelerate its expansion into overseas markets.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Executive Director Lee stated, "Based on my global clinical experience, I will implement local clinical operation strategies and strengthen regulatory capabilities to help Medytox become a truly global company."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.